Executive Summary
Retail outpatient specialty compounding pharmacy with LTC capabilities, located on a hospital campus within a professional medical setting. This asset sale is offered at an asking price of $849,999 and positioned for immediate acquisition. The pharmacy benefits from strong provider relationships and consistent patient flow tied to hospital discharge activity.
Business Overview
• Outpatient pharmacy established in 2024 with 2 years of operation
• Established relationships with hospital physicians, case managers, and social workers
• Active role in servicing outpatient discharge prescriptions
• Strong integration with hospital staff and care coordination teams
Location & Facility
• Located on hospital campus inside professional physician office building
• Approximately 2,500 sq. ft. fully built-out space
• High-visibility, high-referral medical environment
• Lease has 6 months remaining (assignment/renewal details available upon request)
Licenses & Compliance
• Active Texas Pharmacy License (A-S)
• Active DEA registration
• Cleanroom fully validated and compliant with ISO 7 cleanroom and ISO 8 ante room
• Multiple State Board inspections completed with no deficiencies
Insurance & Contracts
• Contracts in place with all major insurance providers
• Continuity of contracts available to qualified buyer
Services & Capabilities
• Sterile and non-sterile compounding
• URAC accredited operation
• Bedside medication delivery service for hospital discharge patients
• Specialty pharmacy services with strong clinical coordination
• Long-term care prescription fulfillment through Dispill with established LTC NCPDP/NPI
Key Value Propositions
• Turnkey sterile compounding operation
• Fully validated cleanroom avoids costly buildout (often $450K-$1M+)
• Immediate revenue from existing outpatient discharge business
• Compliant with latest USP standards reducing buyer risk
Growth Opportunities
• Expansion into additional specialty therapeutic areas
• Development of discharge IV medication services for hospital patients
• Extended operating hours to increase capture rate
• Expansion of referral base within two additional physician office buildings on campus
• Scaling compounding services (GLPs, peptides, HRT, and related therapies)
Owner is selling due to strategic repositioning for ownership group. This represents an excellent opportunity to acquire a fully operational specialty pharmacy with established hospital relationships and significant growth potential.
Ad#:2501706
